HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.

Abstract
Disruption of the circadian rhythm is a contributory factor to clinical and pathophysiological conditions, including cancer, the metabolic syndrome, and inflammation. Chronic and systemic inflammation are a potential trigger of type 2 diabetes and cardiovascular disease and are caused by the infiltration of large numbers of inflammatory macrophages into tissue. Although recent studies identified the circadian clock gene Rev-erbα, a member of the orphan nuclear receptors, as a key mediator between clockwork and inflammation, the molecular mechanism remains unknown. In this study, we demonstrate that Rev-erbα modulates the inflammatory function of macrophages through the direct regulation of Ccl2 expression. Clinical conditions associated with chronic and systemic inflammation, such as aging or obesity, dampened Rev-erbα gene expression in peritoneal macrophages from C57BL/6J mice. Rev-erbα agonists or overexpression of Rev-erbα in the murine macrophage cell line RAW264 suppressed the induction of Ccl2 following an LPS endotoxin challenge. We discovered that Rev-erbα represses Ccl2 expression directly through a Rev-erbα-binding motif in the Ccl2 promoter region. Rev-erbα also suppressed CCL2-activated signals, ERK and p38, which was recovered by the addition of exogenous CCL2. Further, Rev-erbα impaired cell adhesion and migration, which are inflammatory responses activated through the ERK- and p38-signaling pathways, respectively. Peritoneal macrophages from mice lacking Rev-erbα display increases in Ccl2 expression. These data suggest that Rev-erbα regulates the inflammatory infiltration of macrophages through the suppression of Ccl2 expression. Therefore, Rev-erbα may be a key link between aging- or obesity-associated impairment of clockwork and inflammation.
AuthorsShogo Sato, Takuya Sakurai, Junetsu Ogasawara, Motoko Takahashi, Tetsuya Izawa, Kazuhiko Imaizumi, Naoyuki Taniguchi, Hideki Ohno, Takako Kizaki
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 192 Issue 1 Pg. 407-17 (Jan 01 2014) ISSN: 1550-6606 [Electronic] United States
PMID24307731 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CCL2
  • GSK4112
  • Integrin beta1
  • Lipopolysaccharides
  • Nuclear Receptor Subfamily 1, Group D, Member 1
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • Thiophenes
  • Vascular Cell Adhesion Molecule-1
  • p38 Mitogen-Activated Protein Kinases
  • Glycine
Topics
  • Age Factors
  • Animals
  • Cell Adhesion (genetics)
  • Cell Line
  • Cell Movement (genetics, immunology)
  • Chemokine CCL2 (genetics)
  • Circadian Clocks (genetics)
  • Gene Expression
  • Gene Expression Regulation (drug effects)
  • Glycine (analogs & derivatives, pharmacology)
  • Inflammation (genetics, immunology)
  • Integrin beta1 (metabolism)
  • Lipopolysaccharides (immunology)
  • Macrophages (immunology, metabolism)
  • Macrophages, Peritoneal (immunology, metabolism)
  • Male
  • Mice
  • Mice, Knockout
  • Nuclear Receptor Subfamily 1, Group D, Member 1 (agonists, genetics)
  • Nuclear Receptor Subfamily 1, Group F, Member 1 (metabolism)
  • Obesity (genetics, immunology)
  • Phosphorylation
  • Promoter Regions, Genetic
  • Protein Binding
  • Response Elements
  • Thiophenes (pharmacology)
  • Transcriptional Activation
  • Vascular Cell Adhesion Molecule-1 (metabolism)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: